U.S. Divided on Weight-Loss Drugs: Support for Adults, Concerns for Teens
03 Feb 2025
The growing popularity of weight-loss drugs, especially GLP-1 receptor agonists like Ozempic and Wegovy, has sparked a significant debate in the United States. These drugs, originally developed to treat type 2 diabetes, have become widely known for their effectiveness in helping people lose weight, leading to their FDA approval for...
Read More